|  |  |  |  | LR-HPV | HR-HPV | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | N | β-globin | HR-HPV (%) | > 1 genotype (%) | 6 | 11 | 16 | 18 | 26 | 31 | 33 | 35 | 39 | 45 | 51 | 52 | 53 | 56 | 58 | 59 | 66 | 68 | 70 | 73 | 82 |
Cervical cytology | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
normal | 37 | 37 | 9 (24%) | 3 (8%) | 1 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 3 | 1 | 0 | 1 | 2 | 1 | 0 | 0 |
ASCUS1 | 12 | 12 | 6 (50%) | 3 (25%) | 0 | 0 | 0 | 3 | 0 | 0 | 1 | 0 | 1 | 3 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
columnar atypia | 1 | 1 | 1 (100%) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CIN 1 | 24 | 24 | 18 (78%) | 6 (25%) | 2 | 0 | 4 | 2 | 0 | 2 | 3 | 1 | 1 | 2 | 2 | 1 | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 0 |
CIN 2 | 11 | 11 | 11 (100%) | 4 (36%) | 0 | 0 | 7 | 3 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 |
CIN 3 | 4 | 4 | 4 (100%) | 2 (50%) | 0 | 0 | 3 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 |
SCC2 | 9 | 9 | 9 (100%) | 3 (33%) | 0 | 0 | 3 | 1 | 0 | 2 | 2 | 0 | 0 | 1 | 0 | 2 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
subtotal | 98 | 98 | 58 | 21 | 3 | 0 | 18 | 12 | 0 | 7 | 8 | 1 | 3 | 7 | 3 | 5 | 1 | 5 | 5 | 4 | 5 | 3 | 2 | 3 | 2 |
FFPE | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
CIN NOS | 11 | 5 | 11 (100%) | 2 (18%) | 1 | 0 | 3 | 2 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
SCC, cervix | 23 | 13 | 23 (100%) | 2 (9%) | 0 | 0 | 14 | 2 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
ADCA, cervix | 10 | 5 | 9 (90%) | 1 (10%) | 0 | 0 | 5 | 3 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
subtotal | 44 | 23 | 43 | 5 | 1 | 0 | 22 | 7 | 0 | 3 | 0 | 0 | 1 | 2 | 1 | 1 | 1 | 2 | 0 | 2 | 1 | 0 | 0 | 1 | 0 |
FTA | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
SCC3 | 23 | 23 | 22 (96%) | 1 (4%)4 | 1 | 1 | 14 | 1 | 0 | 1 | 1 | 1 | 0 | 2 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 |
ADCA5 | 11 | 11 | 11 (100%) | 1 (9%) | 0 | 0 | 5 | 4 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
SCC neck metastasis | 316 | 31 | 10 (100%)7 | 0 | 0 | 0 | 9 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
subtotal | 65 | 65 | 44 | 2 | 1 | 1 | 28 | 5 | 1 | 3 | 1 | 1 | 0 | 2 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 |
total | 207 | 186 | 145 | 29 | 5 | 1 | 68 | 24 | 1 | 13 | 9 | 2 | 4 | 11 | 4 | 7 | 3 | 8 | 6 | 7 | 6 | 3 | 3 | 5 | 2 |